Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-18-022624

Options or other derivatives

  • EVP, Corporate Development acquired 1,760 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Karp Daniel · EVP, Corporate Development

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-07-02 Grant or award : show line 1 in the form Restricted Stock Unit +1,760 $0.00 2021-07-02 1,760 1,760 D
Loading xslF345X03/form4.xml…